Elevation Oncology Inc (ELEV) Return on Assets ROA from the first quarter of 2025 to first quarter of 2024 and for the year 2025, Average High and Low, Fundamental Ratios from Mar 31 2025 to Mar 31 2024 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Elevation Oncology inc   (NASDAQ: ELEV)


Elevation Oncology Inc 's ROA from the first quarter of 2025 to the first quarter of 2024 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Elevation Oncology Inc 's ROA in the first quarter of 2025?
Elevation Oncology Inc recorded a cumulative net loss of $-48 million during 12 months ending in the first quarter of 2025, resulting in a negative return on assets (ROA) of -48.14%.

However, within the Healthcare sector 600 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Mar 31 2025 quarter, so far to 4148, from total ROA ranking in the fourth quarter of 2024 at 4719.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter
Y / Y Total Assets Change -24.52 % 7.34 % 6.45 % 3.83 % 41.66 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -48 -44 -42 -40 -39
Return On Assets (TTM) -48.14 % -41.82 % -40.05 % -38.5 % -38.56 %
ELEV's Total Ranking # 4148 # 4719 # 4138 # 4131 # 4200
Total Assets (TTM) in million 82 96 106 115 109
Seq. Total Assets Change -14.02 % -10.04 % -7.24 % 5.2 % 22.27 %
Seq. Net Income Change - - - - -

ELEV's 5 Years Annual ROA >> Back to ELEV Management Effectiveness >> Compare ELEV ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 88
Sector # 601
Overall # 4090

Return On Assets Statistics
High Average Low
-11.49 %
-53.57 %
-93.39 %
(Mar 31 2022)   (Mar 31 2023)





Financial Statements
Elevation Oncology Inc 's Assets $ 82 million ELEV's Balance sheet
Elevation Oncology Inc 's Income $ -14 million Quarterly ELEV's Income Statement
ELEV's Income by Division See ELEV's Income by Division



Annual Return On Assets (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
FY
Y / Y Total Assets Change 7.34 % -5.38 % -37.01 % - -
Total Assets in million 96 89 94 149 0
Y / Y Net Income Change - - - - -
Net Income in million -44 -46 -95 -32 0
Annual Return On Assets -46.52 % -51.3 % -100.98 % -21.43 % -

ELEV's 5 Years Annual ROA >> Back to ELEV Management Effectiveness >> Compare ELEV ROA to its Competitors



More Return On Assets Ratios
ELEV's' Return on Assets at Yahoo Finance
Biotechnology & Pharmaceuticals Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
ELEV's Roa Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for ELEV's Competitors
Subscribers only: Roa for Elevation Oncology Inc 's Suppliers
Subscribers only: Return On Assets for ELEV's Customers

You may also want to know
ELEV's Roi ELEV's Inventory Turnover Ratio ELEV's Growth Rates ELEV's Dividend Comparisons
ELEV's Profitability Ratios ELEV's Asset Turnover Ratio ELEV's Dividend Growth
ELEV's Roe ELEV's Valuation Ratios ELEV's Financial Strength Ratios ELEV's Dividend Payout Ratio



Companies with similar Return On Assets at Mar 31 2025, within Healthcare Sector ROA

Date modified: 2026-10-05T11:03:36+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.